The Joint Clinical Research Centre (JCRC) has applied to start trials on injectable HIV/Aids drugs.
The trials seek to administer antiretroviral treatment (ART) on Aids patients using injections instead of the tablets and capsules as is the case currently.
The head of research at the Infectious Diseases Institute at Makerere University, Dr Andrew Kambugu, indicated that long-action injectable ARVs could be the newest innovation in the treatment for HIV/AIDS.
Dr Kambugu told Daily Monitor last week that the US-based research is already showing promising results after it passed the second phase of clinical trials.
In June 2016, it was reported, 362 patients were registered as receiving third line medication after developing drug resistence to first and second lines of treatment.
Jul 03, 2018 Comments Off on When a worker is punished for being honestBy Venansio Ahabwe Mr. Naperi did not acquire a lot of...